Pages that link to "Q45861749"
Jump to navigation
Jump to search
The following pages link to Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12. (Q45861749):
Displaying 14 items.
- The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment (Q33736218) (← links)
- Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity (Q33871059) (← links)
- Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model (Q34116487) (← links)
- Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma (Q35711576) (← links)
- Malignant pleural mesothelioma--an update (Q35740408) (← links)
- Gene therapy of mesothelioma (Q36210859) (← links)
- Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution (Q39740447) (← links)
- Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells (Q40438301) (← links)
- Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma (Q40644787) (← links)
- The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor (Q40684807) (← links)
- CD40-activated B cells contribute to mesothelioma tumor regression. (Q43406455) (← links)
- Endothelial cell-based systemic gene therapy of metastatic melanoma (Q45880325) (← links)
- Mesothelin-family proteins and diagnosis of mesothelioma (Q57297479) (← links)
- Localised spontaneous regression in mesothelioma -- possible immunological mechanism (Q73812309) (← links)